Use of Mosla non-volatile extract in preparing anti-influenza medicine
A non-volatile, influenza virus technology, applied in antiviral agents, pharmaceutical formulations, plant raw materials, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0018] Embodiment 1: Preparation of non-volatile extract of Camelina chinensis
[0019] Take 1000g of medicinal material Mosla hangchowensis Matsuda, grind or cut into small pieces, add 20 times of 70% (v / v) ethanol solution, extract at 70°C for 2h, and concentrate to obtain 283g of extract (yield 28.3 %), the extract is extracted with 1800-2400 mL of ethyl acetate until the hydrochloric acid-magnesium powder reaction is weakly positive or negative [add a little magnesium powder to the ethanol or methanol solution of the extract and shake, then add a few drops of concentrated hydrochloric acid, 1 ~2 minutes (heating on a water bath if necessary) will show red to purple red, then the reaction will be shown as positive, and if there is no color reaction, then it will be shown as negative]. That is the non-volatile extract of ramie ramie, wherein the total flavonoid content of ramie ramie is 50.1%, and the yield is 3.9%.
[0020] chemically separated, 13 C. 1 H-NMR measurement...
Embodiment 2
[0021] Example 2: Experimental research on anti-influenza virus of non-volatile extract of Camelina chinensis
[0022] Take 18-22g ICR mice (provided by Shanghai Experimental Animal Center of Chinese Academy of Sciences / Shanghai Slack Experimental Animal Co., Ltd.), and set up normal control group, virus model group, Tamiflu control group (0.02g / kg) and extract Low dose group (2g crude drug / kg, i.e. 0.15g embodiment 1 extract / kg), middle dose group (4g crude drug / kg, i.e. 0.3g embodiment 1 extract / kg), high dose group (6g crude drug / kg , namely 0.45g embodiment 1 extract / kg). Each group was pre-administered by intragastric administration for 3 days before the challenge, at a rate of 0.2 mL / 10 g of mouse body weight, and continued to administer until the end of the experiment. On the third day, 2 hours after the administration, under light ether anesthesia, the mouse lung-adapted strain A / PR / 8 / 34 of influenza A virus (provided by the Zhejiang Provincial Center for Disease Cont...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com